CLGN
Collplant Biotechnologies Ltd
NASDAQ: CLGN · HEALTHCARE · BIOTECHNOLOGY
$0.37
-4.51% today
Updated 2026-04-29
Market cap
$6.00M
P/E ratio
—
P/S ratio
2.53x
EPS (TTM)
$-0.94
Dividend yield
—
52W range
$0 – $5
Volume
0.1M
Collplant Biotechnologies Ltd (CLGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.86M | $-3.82M | $-3.33M | $-3.72M | $-5.02M | $-4.97M | $-1.22M | $-5.70M | $-4.45M | $2.50M | $-13.70M | $-2.76M | $-14.09M | $-9.42M |
| Capital expenditures | $116238.00 | $136693.00 | $86235.00 | $356473.00 | $127699.00 | $127000.00 | $832000.00 | $1.49M | $437000.00 | $1.43M | $1.27M | $954000.00 | $483000.00 | $28000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $489862.00 | $133233.00 | $52614.00 | $1.05M | $927117.00 | $956000.00 | $1.43M | $1.13M | $1.67M | $1.62M | $2.17M | $1.94M | $1.72M | $999000.00 |
| Free cash flow | $-3.98M | $-3.96M | $-3.41M | $-4.08M | $-5.15M | $-5.09M | $-2.05M | $-7.19M | $-4.89M | $1.07M | $-14.97M | $-3.72M | $-14.58M | $-9.45M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |